299 related articles for article (PubMed ID: 27449712)
1. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
Chawla B; Hasan F; Seth R; Pathy S; Pattebahadur R; Sharma S; Upadhyaya A; Azad R
Ophthalmology; 2016 Sep; 123(9):1933-9. PubMed ID: 27449712
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.
Pérez V; Sampor C; Rey G; Parareda-Salles A; Kopp K; Dabezies AP; Dufort G; Zelter M; López JP; Urbieta M; Alcalde-Ruiz E; Catala-Mora J; Suñol M; Ossandon D; Fandiño AC; Croxatto JO; de Dávila MTG; Reaman G; Ravindranath Y; Chantada GL
JAMA Ophthalmol; 2018 Jul; 136(7):747-752. PubMed ID: 29799944
[TBL] [Abstract][Full Text] [Related]
3. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
[TBL] [Abstract][Full Text] [Related]
4. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH
Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
[TBL] [Abstract][Full Text] [Related]
6. Chemoreduction for unilateral retinoblastoma.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
[TBL] [Abstract][Full Text] [Related]
7. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
[TBL] [Abstract][Full Text] [Related]
8. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
9. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
Künkele A; Jurklies C; Wieland R; Lohmann D; Bornfeld N; Eggert A; Schulte JH
Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458
[TBL] [Abstract][Full Text] [Related]
10. Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective study.
Radhakrishnan V; Kashyap S; Pushker N; Sharma S; Pathy S; Mohanti BK; Vishnubhatla S; Ghose S; Bakhshi S
Ophthalmology; 2012 Jul; 119(7):1470-7. PubMed ID: 22463820
[TBL] [Abstract][Full Text] [Related]
11. Results of a prospective study for the treatment of retinoblastoma.
Chantada G; Fandiño A; Dávila MT; Manzitti J; Raslawski E; Casak S; Schvartzman E
Cancer; 2004 Feb; 100(4):834-42. PubMed ID: 14770442
[TBL] [Abstract][Full Text] [Related]
12. Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease.
Mathew AA; Sachdev N; Staffieri SE; McKenzie JD; Elder JE
J AAPOS; 2015 Feb; 19(1):72-4. PubMed ID: 25727592
[TBL] [Abstract][Full Text] [Related]
13. Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma.
Grümme L; Biewald E; Reschke M; Fischhuber K; Hanbücken A; Schlüter S; Müller B; Kiefer T; Göricke S; Geismar D; Ryl T; Sirin S; Wieland R; Timmermann B; Lohmann D; Ebinger M; Brecht IB; Schönberger S; Schwab C; Eggert A; Süsskind D; Ritter-Sovinz P; Bechrakis NE; Ketteler P
Pediatr Blood Cancer; 2022 Feb; 69(2):e29362. PubMed ID: 34606174
[TBL] [Abstract][Full Text] [Related]
14. First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma.
Beck MN; Balmer A; Dessing C; Pica A; Munier F
J Clin Oncol; 2000 Aug; 18(15):2881-7. PubMed ID: 10920136
[TBL] [Abstract][Full Text] [Related]
15. Treatment of overt extraocular retinoblastoma.
Chantada G; Fandiño A; Casak S; Manzitti J; Raslawski E; Schvartzman E
Med Pediatr Oncol; 2003 Mar; 40(3):158-61. PubMed ID: 12518344
[TBL] [Abstract][Full Text] [Related]
16. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
17. The success of primary chemotherapy for group D heritable retinoblastoma.
Cohen VM; Kingston J; Hungerford JL
Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
[TBL] [Abstract][Full Text] [Related]
18. Preliminary results of primary chemotherapy in retinoblastoma.
Bornfeld N; Schüler A; Bechrakis N; Henze G; Havers W
Klin Padiatr; 1997; 209(4):216-21. PubMed ID: 9293453
[TBL] [Abstract][Full Text] [Related]
19. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
Friedman DL; Himelstein B; Shields CL; Shields JA; Needle M; Miller D; Bunin GR; Meadows AT
J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
[TBL] [Abstract][Full Text] [Related]
20. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
